Printer Friendly
The Free Library
14,504,610 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Hepatitis C topic

Subtopics (46)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN[TM]. Nov 25, 2009 1265
SINGER Boy George and model [...]. Nov 16, 2009 304
Aduro Biotech Completes Series A-1 Financing. Nov 11, 2009 857
United States : Aduro BioTech raises funds through its Series A-1 financing. Nov 11, 2009 460
Medivir: New Phase IIa data on TMC435 In Patients with Hepatitis C Presented at the Ongoing AASLD - Meeting. Nov 4, 2009 623
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009. Nov 3, 2009 871
Avila Presents Data on Its Novel, Orally-Available Protease Inhibitor, AVL-181, Demonstrating Viral Clearance of Hepatitis C Virus in Preclinical Models. Nov 2, 2009 713
United States : Idenix Pharmaceuticals Presents Data On IDX184 For The Treatment Of Hepatitis C Virus (HCV). Clinical report Nov 2, 2009 456
Extending hepatitis C treatment for liver transplant patients may be beneficial. Nov 1, 2009 337
More than 80% of Hepatitis C Patients Treated in Study C208 Achieved an SVR with Telaprevir-Based Regimens. Clinical report Oct 31, 2009 1535
Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C. Oct 31, 2009 1356
Interim Results from Study 107 Highlight the Potential Role of Telaprevir-Based Regimens in HCV Patients Who Failed Prior Treatment. Clinical report Oct 28, 2009 1687
SCYNEXIS to Present HCV Data on Novel Cyclophilin Inhibitor SCY-635 at AASLD Annual Meeting. Oct 28, 2009 273
ZymoGenetics Initiates Phase 2 Clinical Trial of PEG-Interferon lambda in Hepatitis C with Bristol-Myers Squibb. Oct 27, 2009 699
Profectus BioSciences to Present at Upcoming Investor and Industry Conferences. Conference news Oct 27, 2009 322
Research and Markets: Hepatitis C Therapy Area Pipeline Report. Report Oct 27, 2009 378
Inhibitex Announces Data Presentation at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Oct 26, 2009 706
Keeping hepatitis c out. Seppa, Nathan Brief article Oct 24, 2009 116
Coffee slows liver disease progression in chronic hepatitis C patients. Oct 22, 2009 382
Human Genome Sciences Announces $75 Million Milestone Payment for ZALBIN[TM] Progress. Oct 19, 2009 1119
AUC graduate students launched an awareness campaign. Oct 18, 2009 778
Research and Markets: This Essential Disease and Therapy Review on Hepatitis C Provides a Comprehensive Overview of the Disease, Diagnosis and Treatment. Oct 14, 2009 283
Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-2125, a TLR9 Agonist, in Combination with Ribavirin for Chronic Hepatitis C Virus Infection. Oct 7, 2009 904
AUC students launch an HCV awareness campaign. Oct 7, 2009 146
Avila Presents Preclinical Data on its Novel, Orally-Available, Pan-Genotype Protease Inhibitor, AVL-181, Demonstrating Protein Silencing of Hepatitis C Virus. Oct 5, 2009 671
PEGINTRON[R] Receives a Recommendation for Approval from FDA Advisory Committee for a New Application in Melanoma. Oct 5, 2009 518
Bristol-Myers Squibb and ZymoGenetics to Present Final Phase Ib Data on PEG-Interferon Lambda at AASLD 2009. Oct 1, 2009 897
First support group to 'coach' patients suffering hepatitis. Oct 1, 2009 436
Breaking Free from Hepatitis C: A Personal Journey. Book review Oct 1, 2009 94
Vertex Pharmaceuticals Announces Publication of Telaprevir Abstracts for Presentation at the 60th AASLD Meeting. Sep 24, 2009 1054
Hospital unveils hi-tech life saver; HEALTH: pounds 62,000 liver scanner will help in fight against Hepatitis C. Sep 19, 2009 406
Genetic mutation makes some people to rid hepatitis C. Sep 17, 2009 432
United States: Medtronic studies hepatitis C therapy. Sep 3, 2009 388
Medtronic Initiates Phase II Hepatitis C Clinical Study "COPE-HCV" to Determine Tolerability and Safety of Continuous Interferon Infusion for Patients with HCV. Clinical report Sep 2, 2009 726
Hepatitis C therapy impairs sexual function in men. Sep 1, 2009 265
Identification of chronic hepatitis B and hepatitis C co-infection in British Columbia from 1991 to 2007. Fang, Lily; Yu, Amanda; Buxton, Jane A. Report Sep 1, 2009 3234
ANADYS REPORTS NET LOSS OF $6.5 MILLION 2ND QTR 2009. Financial report Sep 1, 2009 1758
Premier Healthcare Alliance Expert to Discuss Safe Injection Practices and Improving Patient Safety at Joint Commission Infection Control Conference. Conference news Aug 19, 2009 411
Egyptian congress focus on hepatitis treatment. Aug 17, 2009 430
Protein key to hepatitis C virus replication identified. Aug 15, 2009 351
Blueberry can help protect against hepatitis C virus infections. Aug 8, 2009 254
Blueberry leaves can halt hepatitis C virus. Aug 8, 2009 233
First human receives new antibody aimed at neutralizing Hepatitis C virus. Aug 7, 2009 484
Dr. Nathaniel Brown Joins Presidio Pharmaceuticals, Inc. as Senior Vice President of Clinical Development. Aug 5, 2009 325
Is contraction of Hepatitis B occupational hazard? Tammelleo, A. David Aug 1, 2009 951
Vertex Pharmaceuticals and Mitsubishi Tanabe Pharma Corporation Amend Agreement to Develop and Commercialize Telaprevir in Asia. Jul 30, 2009 1179
More have hepatitis C. Jul 24, 2009 91
CSIRO Invests A$2M in Avexa's HCV Program. Jul 15, 2009 562
Can-Fite BioPharma to Initiate Phase I/II Clinical Trial with CF102 for the Treatment of Hepatitis C Virus. Jul 14, 2009 547
Vertex Pharmaceuticals Announces Intention to Sell Its Rights to European Milestone Payments for Telaprevir. Jul 10, 2009 560
Presidio Pharmaceuticals Inc. Raises $27 Million in Additional Financing. Jul 9, 2009 391
Presidio Pharmaceuticals, Inc. Selects PPI-461 as a Clinical Candidate in Their Hepatitis C Virus NS5A Program. Jul 7, 2009 239
Addicts get free 'hit kits' at Boots. Jun 27, 2009 573
ADDICTS GET FREE '1 HIT' HEROIN KITS; Campaigner's anger at new strategy: EXCLUSIVE. Jun 26, 2009 354
New weapon helps fight hepatitis C: experimental drug on its way to joining standard medications. Seppa, Nathan May 23, 2009 696
Hepatitis C virus (HCV). Kruger, Corne Report May 1, 2009 1153
Key molecules that inhibit hepatitis C virus production identified. Mar 11, 2009 336
Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia. Buxton, J.A.; Rothon, D.; Durigon, M.; Lem, M.; Tu, A.W.; Remple, V.P.; Cook, D.; Krajden, M. Report Mar 1, 2009 3336
Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges? Vogel, Martin; Page, Emma; Nelson, Mark; Rockstroh, Jurgen K. Report Mar 1, 2009 3867
16th Conference on retroviruses and opportunistic infections, Montreal, Canada, 8-11 February 2009. Bhagani, S Conference news Mar 1, 2009 2277
Contaminated blood delays 'horrific'. Feb 24, 2009 304
Contaminated blood inquiry report due. Feb 23, 2009 376
Contaminated blood delays 'horrific'. Feb 23, 2009 304
Natalie Cole 'to get sister's kidney' to fight Hepatitis C. Jan 22, 2009 145
Hepatitis C linked to pancreatic cancer risk. Jan 14, 2009 289
Patient recovering from hepatitis C turned into liver cirrhosis. Gerson, Charlotte Case study Jan 1, 2009 530
Review of molecular methods for medical microbiology testing. Evans, Gloria Nov 1, 2007 9047
How safe are your facility's infection control and injection practices? Report Sep 1, 2007 875
Are HCWs spreading HCV in ambulatory care? Dec 1, 2004 617
NIH panel favors early HCV testing after stick. Mar 1, 2003 836
Should you screen all new employees for HCV? Sep 1, 2002 1412
Panel: Early treatment of HCV not clear-cut. Aug 1, 2002 259
'It was like being handed a death sentence,' nurse says. Jul 1, 2002 593
Literature Review: Early HCV treatment safe and effective. Jul 1, 2002 679
Literature Review: Patient-doctor-patient transmission a first in U.S. Apr 1, 2002 781
Early HCV treatment may prevent chronic disease. Dec 1, 2001 1095
Hepatitis C: Proven case management strategies. Sep 1, 2001 1244
Hepatitis C cure rates top 40%, but CDC balks at recommending post-exposure prophylaxis policy. Oct 1, 2000 1120
Nurse with HCV tells of hardship and triumph. Oct 1, 2000 720
CDC: No need to restrict employees with hepatitis C. Aug 1, 2000 1180
Known Health Care Workers Who Seroconverted to HIV After Occupational Exposure. Aug 1, 2000 307
Neuropsychiatric Complications of Hepatitis C and Its Treatment. Jul 1, 2000 675
Nurse with HCV sues hospitals for discrimination. Jul 1, 2000 418
New Briefs. Jul 1, 2000 395
HCV may pose greatest risk for needlesticks. Feb 1, 2000 969
Hepatitis C: 12,000 reasons to target this disease. Jan 1, 2000 802
Routine HCV testing considered for high-risk health care workers. Dec 1, 1999 1800
CDC guidelines call for HCV postexposure testing. Dec 1, 1999 458
Hepatitis C study launched. Nov 1, 1999 250
CDC omits safer devices as HCV prevention strategy. Jan 1, 1999 887
Ribavirin Capsules and Interferon alfa-2b. Nov 1, 1998 1389
Hepatitis C: Approach to the HCW with a Potential Exposure. Jan 1, 1998 618
CDC recommends HCV exposure follow-up. Sep 1, 1997 1972
New SHEA guidelines relax restrictions on tasks performed by infected workers. Aug 1, 1997 1804
SHEA lists guidelines for infected HCWs. Aug 1, 1997 697
Literature Review. Aug 1, 1997 486
CDC links hepatitis C to infusion therapy. Aug 1, 1997 310
Hepatitis transmissions pose troubling questions. Jun 1, 1997 2262
Literature Reviews. Nov 1, 1996 560
Literature Reviews. Clinical report Mar 1, 1996 1166

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles